Price Alert

Keryx Biopharmaceuticals ... (KERX)

NASDAQ: KERX · Real-Time Price · USD

3.36

0.00 (0.00%)

At close: Jun 29, 2019, 12:07 AM

Keryx Biopharmaceuticals Revenue

Keryx Biopharmaceuticals reported an annual revenue of $60.64M, reflecting a undefined% growth. For the quarter ending September 30, 2018, Keryx Biopharmaceuticals generated $28.04M in revenue.

Revenue (ttm)

n/a

Revenue Growth

n/a

Price / Sales Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change
Dec 31, 2017	60.64M	+89.60%
Dec 31, 2016	31.98M	+133.79%
Dec 31, 2015	13.68M	+26.37%
Dec 31, 2014	10.82M	+54.64%
Dec 31, 2013	7M	+Infinity%
Dec 31, 2012	0	-100.00%
Dec 31, 2011	5M	+Infinity%
Dec 31, 2010	0	-100.00%
Dec 31, 2009	25.19M	+1863.68%
Dec 31, 2008	1.28M	+22.31%
Dec 31, 2007	1.05M	+96.44%
Dec 31, 2006	534K	-6.97%
Dec 31, 2005	574K	-29.05%
Dec 31, 2004	809K	+Infinity%
Dec 31, 2003	0	n/a
Dec 31, 2002	0	n/a
Dec 31, 2001	0	n/a
Dec 31, 2000	0	n/a
Dec 31, 1999	0	n/a
Dec 31, 1998	0	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.